Contact this trialFirst, we need to learn more about you.
Anti-mitotic Agent
Chemotherapy + Robotic Surgery for Throat Cancer
Recruiting1 awardPhase 2
Montreal, Quebec
This trial tests a new treatment for advanced throat cancer caused by HPV. It uses chemotherapy first, then a precise robotic surgery to remove the cancer. This method aims to reduce the severe side effects of traditional treatments and improve patients' quality of life. Transoral robotic surgery (TORS) has become an accepted initial treatment for T1 and T2 head and neck squamous cell carcinoma (HNSCC).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service